Knocking out ZEB1 in GBM cells inhibits the expression of key glioma stem cell markers, including CD133, SOX2, and OLIG2, thereby suppressing GSC initiation, invasion, and chemoresistance.117. The gene discussed is ZEB1; the disease is central nervous system cancer.